P3 Health PartnersPIII
13F holders, Q2 2025 (June 30)15holders +14
5new positions
1sold out
$6.30avg. 13F price*
At the end of Q2 2025, 15 institutions reported holding P3 Health Partners Inc. (PIII) in their 13F filings, up 14 from Q1 2025. 5 opened new positions and 1 sold out. The largest holders were Alyeska Investment Group, L.P. ($1.1M), Vanguard Group Inc. ($242K) and Corient Private Wealth LP ($223K).
- Company
- P3 Health Partners Inc.
- CUSIP
- 744413204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $18K |
| Exits | 1 | $15K |
All 13F filers, Q1 2025 → Q2 2025: 6,916 shares bought and 104,901 shares sold, net −97,986 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Alyeska Investment Group, L.P. | 0.00% | Reduce -4.1% | 180,906 | $1.1M |
| Vanguard Group Inc. | 0.00% | Add +1.1% | 38,359 | $242K |
| Corient Private Wealth LP | 0.00% | Reduce -9.3% | 35,369 | $223K |
| Geode Capital Management, LLC | 0.00% | Reduce -1.1% | 20,208 | $127K |
| BlackRock, Inc. | 0.00% | Add +32.9% | 10,582 | $67K |
| Blair William & Co. | 0.00% | New | 2,430 | $15K |
| UBS Group AG | 0.00% | Reduce -67.3% | 1,610 | $10K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -4.1% | 1,373 | $9K |
| JPMorgan Chase & Co. | 0.00% | Add +4198.8% | 1,019 | $6K |
| Morgan Stanley | 0.00% | New | 360 | $2K |
| BNP Paribas Financial Markets | 0.00% | Add +13.2% | 250 | $2K |
| Raymond James Financial Inc. | 0.00% | New | 47 | $296 |
| Bank of America Corp. | 0.00% | Add +5.3% | 16 | $101 |
| FMR LLC | 0.00% | New | 2 | $13 |
| Royal Bank of Canada | 0.00% | New | 2 | $0 |
"% of holder's portfolio" is PIII's weight in each manager's 13F, not the share of P3 Health Partners Inc. the manager owns.